Ölgerðin Egill Skallagrímsson (OLGERD) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
25 Nov, 2025Executive summary
Operations remained strong in the first nine months, with stable sales after a period of significant growth, despite external challenges.
EBITDA for the period was ISK 3,872 million, down ISK 608 million year-over-year, mainly due to higher wage and marketing costs.
Net profit was ISK 1,980 million, a decrease of ISK 902 million; adjusted for one-time income last year, profit fell by 21%.
New shares were issued to meet exercised stock options, and a dividend of ISK 1,419 million was paid.
Financial highlights
Revenue for the period was ISK 35,286 million, nearly flat year-over-year.
EBITDA fell 14% to ISK 3,872 million; EBIT dropped 18% to ISK 3,035 million.
Net profit for the period was ISK 1,980 million, down 31% from the previous year.
Total assets increased to ISK 33,559 million, and equity rose to ISK 15,771 million.
Net interest-bearing debt, including lease liabilities, was ISK 9,017 million, up ISK 3,262 million since the start of the year.
Outlook and guidance
Focus for Collab export narrowed to Denmark and northern Germany, based on market research and success in Denmark.
New distribution center and water bottling plant planned at Hólmsheiði to improve efficiency and support future growth.
Latest events from Ölgerðin Egill Skallagrímsson
- Q3 2025 saw robust domestic growth, new acquisitions, and a major group restructuring.OLGERD
Q3 202618 Dec 2025 - 2024 saw stable revenue, lower profit, and strategic moves for future growth.OLGERD
Q4 202518 Dec 2025 - EBITDA and profit declined on flat sales, but equity and strategic investments increased.OLGERD
Q2 202518 Dec 2025 - Sales grew 3.3% but EBITDA fell 8%; guidance unchanged amid acquisitions and new launches.OLGERD
Q1 202625 Nov 2025 - Revenue up 2% but net profit down sharply; focus on sustainability and new products.OLGERD
Q1 202525 Nov 2025 - Revenue up 2.7% year-over-year, but EBITDA and net profit declined on higher costs.OLGERD
Q2 202612 Oct 2025